ChiCTR-INR-16010046
尚未开始
/
/
/
2016-11-24
/
/
頸部肌筋膜疼痛
保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程
保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程
保雲療法在治療頸部肌筋膜疼痛成效之前瞻隨機性研究及改善由護士轉介的分流過程
随机平行对照
治疗新技术
Randomized control trial
Single-blind: Investigator/research team
Department of Anaesthesia & Intensive Care, Department of Occupational Therapy, PWH
/
90
/
1990-01-01
1990-01-01
/
Consenting adult (age 18-75) with subacute or chronic myofascial neck problem with at least 1 trigger point presents at the neck region, and agrees to discontinue other alternative treatments once giving consent to participate unless approved by the investigators.；
登录查看Patient refusal, pregnancy, confirmed to be unsuitable to participate by pain specialists due to the presence of urgent or severe co-morbidities or conditions, known severe psychiatric illness, known malignancy, skin disease, infectious disease, severe cardiovascular disease, patients taking anti-coagulants, and patients who are being randomized to receive Bowen therapy (Group 2), receiving concurrent treatment or intervention for pain control such as alternative medicine, physiotherapy, chiropractor, but refuse to discontinue during study period will be excluded.；
登录查看Department of Anaesthesia & Intensive care, Prince of Wales Hospital, CUHK
/
精准药物2024-11-22
亚泰制药2024-11-22
医药时间2024-11-21
一度医药2024-11-21
新药创始人2024-11-21
细胞与基因治疗领域2024-11-21
细胞与基因治疗领域2024-11-21
细胞与基因治疗领域2024-11-21
细胞与基因治疗领域2024-11-21
药时空2024-11-21
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
